Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration	CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Leukoencephalopathies, Nerve Degeneration, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sclerosis, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, central nervous system disorder, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder	Active, not recruiting	Phase 2	2025-06-24		NCT05893225

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AZ Sint-Jan AV	28
Hasselt University	41
National MS Center Melsbroek	4
Noorderhart Pelt	2
University Hospital, Antwerp	108
University Hospital, Ghent	163

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Antwerp University Hospital	Edegem	Belgium	6
AZ Sint-Jan Brugge	Bruges	Belgium	10
National MS Center Melsbroek	Melsbroek	Belgium	2
Noorderhart	Overpelt	Belgium	1
University Hospital Ghent	Ghent	Belgium	6